l-carnitine and tmao γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to Frontiers | Gut Microbiota-Dependent Marker

Frontiers Gut Microbiota Dependent Marker TMAO in Promoting Cardiovascular Disease: Inflammation Mechanism, Clinical Prognostic, and Potential as a Therapeutic Target Dietary allicin reduces transformation of L carnitine to TMAO through impact on gut microbiota ScienceDirect JCI l Carnitine in omnivorous diets induces an atherogenic gut microbial pathway in humans Frontiers The gut microbial metabolite trimethylamine N oxide and cardiovascular diseases Frontiers Effect of a polyphenol rich pomegranate extract on plasma trimethylamine N oxide levels following an oral carnitine challenge: a randomized controlled crossover trial in healthy adults

SKU: 29775821836 · From crisbcreativa.com